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Sllmnls.ry 
Mice were thymectomized and depleted of CD4 § lymphocytes by treatment with monoclonal 
antibody to induce Pneumocystis carinii  (PC) pneumonia (PCP). These mice were then exposed 
to aerosols of heat-treated Escherichia  coli three times a week. Aerosol treatment for 10 d caused 
a slight reduction in numbers of PC nuclei in the lungs of mice, and treatment for 22 d resulted 
in nearly complete resolution of PCP. Large numbers of macrophages, polymorphonuclear leu- 
kocytes,  and  lymphocytes accumulated  in  lungs  of aerosol-treated  mice.  Depletion  of either 
CD8 + lymphocytes or asialo GM1 + cells that remained in the mice after CD4 + cell depletion 
had no effect on the ability of the mice to resolve PCP after E. coli aerosol treatments.  However, 
depletion of Thy-1 + lymphocytes in these mice abrogated their ability to resolve PCP and re- 
duced the numbers of macrophages  that  accumulated in the lungs.  In addition,  it was found 
that resolution of PCP induced by heat-treated E. coli aerosol treatments was also abrogated when 
mice were treated with polyclonal antibodies against tumor necrosis factor ot (TNF-ot). Thus, 
resolution of PCP in CD4 + lymphocyte-depleted mice by heat-treated E. coli aerosols was not 
dependent  on either CD8 + or asialo  GM1 + cells but was dependent  on Thy-1 +  CD4-CDS- 
lymphocytes and on the participation  of TNF.  These results indicate  that  heat-treated E.  coli 
aerosols can act as an immune response modifier by inducing  resolution of PCP in mice by a 
mechanism  not dependent  on the presence of CD4 §  lymphocytes. 
C 
ertain immunocompromised individuals, such as AIDS 
patients, are susceptible to Pneurnocystis carinii (PC) pneu- 
monia (PCP), whereas immunocompetent individuals are resis- 
tant.  That  susceptible  individuals  usually  have  deficient 
CD4 + lymphocyte function suggests that these cells are im- 
portant  in resistance to PCP (1).  Indeed,  studies in animal 
models of PCP have confirmed that depletion of host CD4 + 
lymphocytes increases susceptibility to PCP (2, 3). However, 
the importance of possible defense mechanisms  not depen- 
dent  on CD4 + lymphocytes has not been established. 
One study that has investigated possible CD4 + lympho- 
cyte-independent defense mechanisms against PC is that by 
Pesanti (4). He found that pulmonary infection by Pseudo- 
monas aeruginosa  increased resistance of rats  to  subsequent 
corticosteroid-induced Pneumocystis  infection, whereas similar 
pulmonary infection with Staphylococcus  aureus did not. Be- 
cause Pseudomonas,  but not Staphylococcus  infection, caused 
an accumulation of neutrophils in the lung, Pesanti concluded 
that neutrophil  contact with dormant Pneurnocystis  delayed 
the onset of subsequent corticosteroid-induced Pneumocystis 
infection. Although not discussed by Pesanti, it is also pos- 
sible that endotoxin associated with the cell walls of the Gram- 
negative Pseudomonas caused the enhanced resistance.  Endo- 
toxins from Gram-negative bacteria are known to be potent 
immune response modifiers (5), and treatment of animals with 
endotoxin can enhance their resistance to infectious microbes 
(6) and some tumors (7).  It is believed that  endotoxin en- 
hances  resistance  through  effects  on  both  specific  and 
nonspecific defense mechanisms (7). However, it is not known 
whether immune response modifiers such as endotoxin can 
enhance  resistance  to Pneumocystis  in  CD4 +  lymphocyte- 
deficient hosts. If such inducible defense mechanisms exist, 
they would make attractive  targets for immunotherapy against 
PCP in AIDS patients. 
The purpose of this study was to determine whether an 
aerosol of heat-treated E. coli could enhance resistance  to PCP 
in  mice  chronically  depleted  of CD4 +  lymphocytes.  An 
aerosol of heat-treated E.  coli was used because it has been 
shown to cause pulmonary inflammation similar to that ob- 
served for aerosols of endotoxin (8). In addition, in prelimi- 
nary experiments we found that mice became tolerant to mul- 
tiple aerosol exposures of endotoxin but not to heat-treated 
E. coll. Results of the present investigation indicate that heat- 
treated E. coli aerosol treatment can induce resolution of PCP 
in mice depleted of CD4 §  lymphocytes.  In additional  ex- 
periments, it was found that this resolution was not depen- 
dent on either CD8 + or asialo GM1 + lymphocytes, but was 
dependent on Thy-1 + CD4-CDS-  lymphocytes and TNF. 
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Mice.  Female B6D2F1  (C57BL/6J  x  DBA/2J) mice used in 
these  studies  were  supplied  by  the  Trudean  Institute  Animal 
Breeding Facility (Saranac Lake, NY). Mice were maintained under 
standard husbandry conditions in open-topped cages in a conven- 
tional animal room. 
AerosoI Exposures of  Mice to Heat-treated E. coll.  Lyophilized cells 
of strain W  (9637;  American Type Culture Collection [ATCC l, 
Rockville, MD) E. coli were purchased from Sigma Chemical Co. 
(St. Louis, MO).  1 g of the E. coli cells was suspended in 100 ml 
water and boiled for 45 min to remove the capsular antigens ex- 
posing the O antigens (8). The cells were then washed several times 
and resuspended in 20 rrd of sterile water, aliquoted,  and kept frozen 
at  -70~  For aerosol exposures,  1 ml of the E. coil suspension 
was thawed, added to 4 ml of sterile water, and placed in the reser- 
voir of a T updraft nebulizer (Hudson, Temecula, CA). The solu- 
tion  was  then  nebulized  under  •20  lb/in  2 air pressure  and  an 
airflow rate of"o6 liters/rain. The nebulized solution then flowed 
into  a  20  x  20  x  40-cm  plexiglass  chamber  that  contained 
the mice. 
Antibodies and FACS |  Analysis.  The hybridoma GK 1.5 (Dr. 
Frank Fitch, University of Chicago, Chicago, IL) secreting rat IgG2b 
anti-CD4 mAb, hybridoma TIB-210 (ATCC) producing rat IgG2b 
anti-CD8, hybridoma 30-H12 (ATCC) producing rat IgG2b anti- 
Thy-l.2, and hybridoma HB151 (ATCC) producing rat IgG2b anti- 
HLA-DR5 were raised as ascites and purified by ammonium sul- 
fate precipitation. Rabbit polyclonal antibodies against TNF-c~ and 
control rabbit Ig were produced and purified as described elsewhere 
(9), and were the gift of Dr. Edward Have11 (Trudean Institute). 
Rabbit anti-asialo GM1 was purchased from Wako Chemicals (Rich- 
mond, VA). 
FITC-conjugated F(ab')2 fragments of anti-Thy-l.2, anti-CD4, 
and anti-CD8 were prepared as described elsewhere (10) and used 
to stain lung lavage cells. Asialo GMI* cells were enumerated by 
utilizing anti-asialo  GM1 as a first antibody and F(ab')2 fragments 
of  FITC-conjugated  goat  anti-rabbit  Ig  (Organon  Teknika, 
Durham, NC) as a secondary antibody. Fluorescence  was measured 
using a FACScan |  cytofluorometer (Becton Dickinson & Co., Sun- 
nyvale, CA). Calls from lung lavage fluids were collected by lung 
lavage and processed as previously described (11). 
Depletion  of  CD4 §  CD8 §  Thy-l.2 +,  and  Asialo  GMI + 
Cells.  B6D2 mice were made susceptible to PCP by chronic deple- 
tion of CD4 + cells as previously described (3).  Briefly, 4-wk-old 
mice were thymectomized, rested for 2 wk,  and then given 0.5 
mg of GK1.5 once a week as an intraperitoneal injection.  After 
5 wk,  the mice were inoculated intratracheally (11) with 0.1  ml 
of  SCID  mouse  lung  homogenate  containing  5  x  10  s  PC 
nuclei/ml. Some of the mice were used in experiments after 3 wk 
of additional GK1.5 injections. Other mice received a second in- 
oculation of PC 2 wk after the first and were used in experiments 
after an additional 5 wk.  All mice remained on anti-CD4 treat- 
ment the entire time of the experiments. 
Some mice were treated with additional mAbs (anti-CD8 or anti- 
Thy-l.2; 0.5 mg) or anti-asialo GM1 serum (40 #1) by intraperitoneal 
injections twice weekly beginning on the first day ofE. coli aerosol 
exposure and extending to the end of the experiment. As controls, 
one group of mice not exposed to E. coli aerosols and one group 
exposed to E. coli aerosols both received intraperitoneal injections 
of HB151  (anti-HLA-DR5; 0.5 rag) twice a week also beginning 
on the first day of aerosol exposures. 
Enumeration of PC in Lungs of Mice.  The number of PC nuclei 
in the lungs of mice was determined as described elsewhere (12), 
but  with  some modifications,  as described previously (3).  This 
method entails pushing the lungs through a stainless  steel screen 
into HBSS, diluting the homogenate, and making a cytocentrifuge 
prepared smear. The smear was stained with Diff-Quick (Amer- 
ican Scientific Products, McGaw Park, IL) and the number of PC 
nuclei per 20-40 oil emersion fields determined. This number was 
then used to calculate total PC nuclei per lung. With this method, 
one nuclei counted in 40 fields equates to slightly more than 104 
PC nuclei per lung. Therefore, 1041 PC nuclei was considered the 
limit of detectability. 
Statistics.  The significance of differences in means of cell numbers 
in the lungs of groups of mice was evaluated utilizing  the Stu- 
dent's t test (two tailed),  whereas that for PC numbers was calcu- 
lated utilizing  the Mann-Whitney U  test (two tailed). 
Results 
Effect of  E. coli Aerosol Treatment on Numbers of  PC in Lungs 
of  Mice.  B6D2 mice that received only one inoculation of PC 
were divided into two groups.  One group was exposed to 
heat-treated E.  coli aerosols and the other group was left as 
Table  1.  Numbers of PC Nuclei  in the Lungs of CD4 + Lymphocyte-depleted Mice after Treatment  with 
Heat-killed E. coli Aerosols 
No.  of mice with 
Treatment  Duration  No.  of PC nuclei  undetectable*  no.  of PC/total  mice 
d  loglo per lung 
Control  10  6.37  _.  0.66*  0/5 
E.  coli exposed  10  5.32  +  0.49s  0/5 
Control  22  6.73  +  0.49  0/5 
E. coil exposed  22  4.37  _+  0.60 ff  4/5 
* The limit of detectability for PC in the lungs was 4.1  (log10). 
t Numbers are means _+  1 SD; n  =  5 mice. 
S  p  =  0.0947 vs.  10-d control group (Mann-Whitney  U test,  two tails). 
n p  =  0.0122 vs. 22-d control group  (Mann-Whitney  U test,  two tails). 
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with Heat-killed E. coli Aerosols 
No. of cells in lung lavage fluid 
Treatment  Duration  Macrophages  Lymphocytes  PMN 
d  ￿  ~ 
Control  10  0.11  _+  0.12"  0.39  _+ 0.29  0.13  -+  0.18 
E. coli exposed  10  1.23  _+  0.80*  2.37  _+  1.03'  8.34  _+  1.02s 
Control  22  0.14  _+  0.06  0.58  _+ 0.34  0.07  _+  0.07 
E. coli exposed  22  0.80  +  0.40*  4.72  _+  1.48,  14.8  _+  2.86s 
* Numbers are means _+  1 SD; n z  5 mice. 
*  p ~  0.05 vs. respective  control (Student's t test, two tails). 
$  p ~  0.01 vs. respective  control (Student's t test, two tails). 
controls. After 10 or 22 d, five mice each from control and 
from the exposed group were killed. Their lungs were lavaged, 
excised,  and processed for PC counts. The numbers of PC 
nuclei in the lungs of these mice are shown in Table 1. After 
10 d of aerosol treatment, PC numbers were reduced in the 
lungs of mice, but not significantly. However, after 22 d, 
mice treated with the E.  coli aerosols had >100-fold fewer 
PC in their lungs than did the controls not given the aero- 
sols (p =  0.0122).  In fact, only one of five mice in the aerosol- 
exposed group contained detectable numbers of PC in their 
lungs after 22 d  of aerosol treatment, whereas all mice in 
the other groups contained detectable numbers of PC. 
The numbers of various leukocytes in lung lavage fluids 
of CD4 §  lymphocyte-depleted mice after treatment with 
heat-killed E. coli aerosols are shown in Table 2. After 10 d, 
Table  3.  Numbers of PC Nuclei in the Lungs  of CD4 + 
Lymphocyte-depleted Mice after Treatment with Heat-killed 
E. coli Aerosols and Antibodies to  Various Cells 
Treatment  No. of PC nuclei 
No. of mice with 
undetectable* no. of 
PC/total mice 
loglo per lung 
Control  +  control Ig  7.27  +_  0.32  (7)*  0/7 
E. coli +  control Ig  4.79  _+  0.87  (7)s  4/7 
E. coli +  c~-CD8  4.56  _+  0.72  (8) II  5/8 
E. coli +  c~-asialo  4.63  +  0.76  (8) II  5/8 
E. coli +  c~-Thy-l.2  6.84  _+ 0.44 (8)  0/8 
All animals were killed 21 d after the first exposure to E. coli aerosol. 
* The limit of detectability for PC in the lungs was 4.1 (log10). 
* Numbers are means _+  1 SD (numbers of mice). Results are from one 
of three experiments with similar results. 
Sp  -  0.0022 vs. either control or E. coli + cx-Thy-1  group (Mann- 
Whitney U test, two tails). 
lip  m 0.0015 vs. control (Mann-Whitney U test, two tails). 
mice treated with the aerosols had significantly more macro- 
phages, lymphocytes, and PMN in their lungs that did con- 
trols (p <  0.05). This increase in all three types of cells was 
still observed at 22 d  of aerosol exposure (p ~  0.05). 
Effect of Depletion  of Various Lymphocytes  on Resolution  of 
PCP. B6D2 mice that had been thymectomized, depleted of 
CD4 §  lymphocytes,  and  inoculated  with  PC  two  times 
were split into five groups. These mice had greater numbers 
of PC in their lungs at the start of E. coli aerosol treatment 
than did mice in the previous experiment as a result of the 
additional inoculation and longer anti-CD4 treatment. As 
control, one group of mice did not receive aerosol treatment 
but was given intraperitoneal injections of anti-HLA-DKS. 
The other four groups all received E. coli aerosol treatments 
three times a week. Each of these four groups of mice also 
received twice weekly intraperitoneal injections of antibodies 
that included anti-Thy-l.2, anti-CDS, anti-asialo GM1, and 
anti-HLA-DK5  as  control Ig.  At  21  d  after  the  start  of 
E. coli aerosol and antibody injections, the mice were killed 
and the numbers of PC and different cell types in their lungs 
determined. The results representing one of three experiments 
are shown in Table 3. Again, E. coli aerosol treatment caused 
nearly complete resolution of PCP in CD4 + lymphocyte- 
depleted mice. Treatment of mice with either anti-CD8 or 
anti-asialo had no significant effect on the aerosol-induced 
resolution of PCP. However, treatment with anti-Thy-l.2 elim- 
inated  the  ability  of mice  to  resolve PCP  in  response to 
E.  coli aerosol treatment. 
The numbers of various leukocytes in lung lavage fluids 
of CD4 + lymphocyte-depleted mice after treatments with 
heat-killed E. coli aerosols and antibodies to various cells are 
shown in Table 4. The numbers of macrophages, lympho- 
cytes, and PMN in lungs of the control mice are higher than 
those shown for control mice in Table 2. The values shown 
in Table 4 are from mice with much heavier burdens of PC, 
and we have consistently found that inflammatory cells ac- 
cumulate in the lungs of mice as their PC burdens increase. 
In this regard, as shown in Table 4, E. coli aerosol treatment 
had little additional effect on macrophage, lymphocyte, and 
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with  Heat-killed E.  coli Aerosols and Antibodies  to  Various  Cells 
No. of cells in lung lavage fluid 
Treatment  Macrophages  Lymphocytes  PMN 
x  lO  ~ 
Control  +  control Ig  0.80  +_  0.11"  0.43  _+  0.20  2.52  _+  0.45 
E.  coli  +  control Ig  1.03  +_  0.59  1.14  _+  0.29  2.92  +  1.16 
E.  coil  +  cx-CD8  0.89  _+  0.42  1.18  _+  0.26  1.92  _+  0.18 
E.  coli  +  c~-asialo  1.35  _+  0.37  2.66  _+  1.11  3.39  _+  0.97 
E.  coli  +  c~-Thy-l.2  0.39  _+  0.07  0.34  +  0.11*  1.24  _+ 0.54 
* Numbers are means  _+  1 SD;  n  =  3  mice. 
* p  <  0.05  vs. E.  coli  +  control Ig (Student's t  test, two-tailed). 
PMN numbers. In addition, neither anti-CD8 nor anti-asialo 
GM1 affected the accumulation of these inflammatory cells, 
whereas anti-Thy-l.2 treatment did reduce macrophage, PMN, 
and lymphocyte accumulation, with the latter cell  being 
significantly (p <0.05) reduced in number. 
The numbers oflymphocytes staining positively for CD4, 
CDS, Thy-1, or asialo GM1 present in lung lavage fluids of 
CD4 §  lymphocyte-depleted mice  that  were  treated with 
heat-killed E.  coli  aerosols  and antibodies to  these surface 
markers were determined cytofluorometricaUy. The results 
in Table 5 show that CD4 § lymphocytes were undetectable 
in all groups of mice, thus confirming the ef~cacy of the 
CD4 § lymphocyte depletion protocol. In addition, CD8 +, 
Thy-l.2 + or asialo GM1 + cells were each depleted by respec- 
tive treatments with mAbs or antibodies.  It is also interesting 
to note that in mice depleted of CD8 + lymphocytes, a large 
number  of  Thy-l.2 +  lymphocytes  accumulated  in  their 
lungs and that these cells did not stain with either anti-CD4 
or anti-CD8 reagents. 
Effect of  Anti-TNF-ot  Treatment on E. coli Aerosol-induced Reso- 
lution  of PCP.  The ability of CD4 § lymphocyte-depleted 
mice to respond to heat-treated E. coli aerosols by the produc- 
tion of TNF was determined. Mice were divided into three 
groups of four mice each, one of which received eight E. coli 
aerosol exposures (three times per week), another received 
one aerosol exposure, and the last group was not exposed 
to E.  coli aerosols  and served as control. 6 h  after the last 
exposure, the mice were killed, and TNF activity in homog- 
enates of their lungs was determined as previously described 
(13). All control mice not exposed to the E. coli aerosols con- 
tained TNF activity of ~<20 U/lung. Mice exposed once to 
E. coli aerosols contained 160 (range,  160-320)  U/lung, and 
all mice exposed eight times contained 320 U/lung. The limit 
of detectability for TNF activity is 20 U/lung. Thus, TNF 
activity was not detected in lungs of mice not exposed  to 
E. coli aerosols, whereas substantial activity was detected after 
a single aerosol exposure and this activity persisted  through 
eight aerosol exposures. 
Whether TNF plays a role in resolution of PCP induced 
by E. coli aerosols was investigated. Mice depleted of CD4 + 
Table  5.  Numbers  of Various  Lymphocytes  in  Lung  Lavage Fluids  of CD4 + Lymphocyte-depleted  Mice after  Treatments  with 
Heat-killed E.  coli Aerosols and Antibodies  to  Various  Cells 
No. of cells in lung lavage fluid 
Treatment  CD4 §  CD8 §  Thy-1 §  Asialo  GM1 
x10* 
Control  +  control  Ig  <0.01"  1.31  _+  0.55  1.40  _+  0.57  0.91  _+  0.25 
E.  coli  +  control  Ig  <0.01  1.34  +  0.66  1.59  _+  0.73  0.70  +  0.16 
E.  coli  +  cx-CD8  <0.01  <0.01  0.91  _+  0.19  0.47  _+  0.17 
E.  coli  +  ~x-asialo GM1  <0.01  1.77  +_  0.39  2.02  _+  0.30  0.05  _+  0.06 
E.  coli  +  ol-Thy-l.2  <0.01  0.13  +  0.06  0.07  +  0.05  0.10  _+  0.07 
All animals were killed 21 d after the first exposure to E. coil aerosol. Antibodies were given on the day of first exposure and every 3-4 d thereafter. 
* Numbers are means  _+  1 SD;  ,  =  3  mice. 
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Lymphocyte-depleted Mice after Exposure  to Heat-killed 
E.  coli Aerosols and Treatment  with Anti-TNF~ 
Treatment  No.  of PC  nuclei 
No.  of mice with 
undetectable  no.  of 
PC/total  mice 
log~o per lung 
Control  6.41  +  0.37  (4)*  0/4 
E.  coli  +  control IgG  4.97  _+  0.94  (7)  3/7 
E.  coli  +  tx-TNF IgG  6.21 _+  1.09 (7)*  1/7s 
All mice were killed 19 d after first exposure  to E. coil aerosol. Control 
IgG or anti-TNF-tx IgG (104 NU) was given intraperitoneally  2 h be- 
fore each aerosol exposure. 
" Numbers are means  +_  1 SD (numbers  of mice) in one of two experi- 
ments with similar results. 
* p  =  0.0181 vs. control IgG group (Mann-Whitney U test,  two tails). 
s p  >  0.05  vs. control IgG group (Fisher's  exact  test). 
lymphocytes were divided into three groups. One group was 
not exposed to E. coli aerosols and served as a control. Two 
other groups of mice were exposed to E.  coli aerosols  three 
times a week. Mice in one of these groups were given anti- 
TNF  IgG  (10  4  NU)  intraperitoneally  2  h  before  each 
aerosol, and mice in the other group received an equivalent 
amount of control IgG before each aerosol exposure. At 19 d 
after the first aerosol exposure,  the mice were killed and 
numbers of PC nuclei in their lungs determined. Results are 
shown in Table 6.  As found in the above experiments, the 
E. coli aerosol treatment significantly reduced numbers of PC 
nuclei in the lungs of mice. However, treatment of the aerosol- 
exposed mice with anti-TNF IgG significantly reduced the 
ability of the mice to resolve PCP as judged by mean numbers 
of PC nuclei. 
Discussion 
Our results show that aerosols  of heat-treated E.  coli in- 
duce resolution of PCP in mice depleted of CD4 + lympho- 
cytes.  Pesanti (4) found that bacterial pneumonia resulting 
in acute pulmonary inflammation rendered rats more resis- 
tant to PCP.  In this regard, the heat-treated E.  coli aerosol 
used in the present investigation also induced an acute inflam- 
matory response characterized by an accumulation of macro- 
phages, lymphocytes, and PMN (Table 2). The ability of the 
E. coli aerosol to induce such an inflammatory response may 
be the result of the presence of endotoxins in these organisms. 
Indeed, aerosols of heat-treated E. coli do cause an inflamma- 
tory response in the lungs similar to that caused by aerosols 
of endotoxin (8).  It is believed that boiling the E.  coli re- 
moves capsular antigens thus exposing O antigens (8), which 
are associated with the lipopolysaccharides of the organism. 
It is also possible that the ability of the E. coli aerosol to cause 
resolution of PCP could reside in a component of the E. coli 
cell wall that is not endotoxin related. Such components have 
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been described and some have biological activities similar to 
endotoxin (14). Future studies will attempt to identify the 
cell wall component responsible for inducing resolution of 
PCP. 
Macrophages and neutrophils did accumulate in the lungs 
of mice treated with heat-treated E. coli aerosols but whether 
these cells play a central role in the resolution of PCP caused 
by  the  aerosol  treatment  is  not  known.  We  found  that 
CD4 +  lymphocyte-depleted mice  with  few  PC  in  their 
lungs (Table 2) also had few macrophages and neutrophils 
in their alveoli,  whereas mice with larger numbers of PC 
also had larger numbers of alveolar macrophages and neutro- 
phils in their lungs (Table 4) regardless of whether they had 
been exposed to E.  coli aerosols.  These results suggest that 
accumulation of inflammatory phagocytes in the lungs alone 
is not sufficient for resolution of PCP. However, depletion 
of Thy-1 +  cells  resulted in reduction of macrophage and 
neutrophil accumulation in the lungs, and it is possible that 
this effect on phagocytic accumulation caused a decrease in 
resistance to PC. If indeed phagocytes are capable of killing 
PC as others have suggested (15, 16), it is possible that this 
process is dependent on soluble factors (cytokines) that could 
have been induced by the heat-treated E.  coli  aerosols. 
One factor that is known to mediate phagocytic cell func- 
tion is TNF. For this reason and for the reason that endo- 
toxin is known to be a potent inducer of TNF (17, 18), we 
investigated the role of TNF in E. coli aerosol-induced reso- 
lution of PCP. We found that aerosol treatment did indeed 
cause production  of TNF  in  lungs  of mice  depleted  of 
CD4 +  lymphocytes. Furthermore,  treatment  of mice ex- 
posed to E. coli aerosols with anti-TNF IgG ablated the ability 
of the mice to resolve PCP.  Thus,  TNF  appears  to play a 
role in the resistance to PC induced by E. coli aerosols.  This 
is consistent with our previous finding that TNF is required 
in host resistance to PC induced by immunological reconsti- 
tution of SCID mice (13).  It is not known how TNF en- 
hances host resistance to PC, but that TNF is important in 
both CD4 + lymphocyte-dependent and independent resolu- 
tion of PCP implies that this cytokine plays a pivotal role. 
Results of the present investigation also indicate that reso- 
lution of PCP in CD4 + lymphocyte-depleted mice is depen- 
dent on Thy-1 + CD4-CDS-  lymphocytes. The exact iden- 
tity of this  cell is  not  known,  but  results  of the present 
investigation indicate  that  the Thy-1 +  CD4-CDS-  cells 
probably are not NK cells since depletion of asialo GM1 + 
cells had no effect on the ability of mice to resolve PCP. There- 
fore,  these cells  are probably either Thy-1 +  CD4-CD8- 
tx//3 T cells or Thy-1 + CD4-CD8-  3'/~ T cells. Dunn and 
North (10) described a similar cell type in mice depleted of 
both CD4 + and CD8 §  cells and showed these cells to be 
important in resistance to Listeria monocytogenes.  Regardless 
of the identity of the cell involved, results presented indicate 
that resistance to PCP can be induced in CD4 + lymphocyte- 
depleted mice and that such resistance is dependent on Thy-1 + 
CD4-CD8-  lymphocytes. These results do not contradict 
previously published results that show that CD4 + lympho- 
cytes are required for resistance to PCP in mice (2, 3). It is 
possible  that  in  the  present  experiments E.  coli  aerosols 
Definitive Report "replaced" some function normally accomplished by CD4 § 
lymphocytes. Thus, resistance to PCP in immunocompetent 
hosts could require both CD4 + and Thy-1 + CD4-CDS- 
lymphocytes.  Alternatively,  the  mechanisms  involved  in 
Thy-1 +  CD4-CD8-  lymphocyte-dependent resistance  to 
PCP might be independent of CD4 § lymphocytes. It is pos- 
sible for example, that chronic depletion of CD4 § lympho- 
cytes results  in the depletion of an additional cell type that 
normally  functions  together  with  Thy-1 +  CD4-CDS- 
lymphocytes in resistance to PCP. Thus, CD4 + lyrnphocytes 
and Thy-1 + CD4- CD8-  lymphocytes may be parts of the 
same pathway that leads to resistance  to PCP,  or each cell 
may be part of separate  pathways. 
In conclusion, results of the present investigation indicate 
that heat-treated E. coli aerosols act as an immune response 
modifier by enhancing resistance  to PCP in mice depleted 
of CD4 + lymphocytes. This induced resistance was depen- 
dent on the presence of Thy-1 + CD4-CD8-  lymphocytes. 
Whether AIDS patients possess equivalent cells that could 
also be stimulated by immune response  modifiers resulting 
in enhanced resistance  to PCP is not known. However, if 
such potential resistance exists in humans, it could represent 
a possible  target for activation by immunologic therapy. 
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